Found: 5
Select item for more details and to access through your institution.
Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 4, p. 1033, doi. 10.3390/pharmaceutics15041033
- By:
- Publication type:
- Article
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.
- Published in:
- Pediatric Rheumatology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12969-023-00930-8
- By:
- Publication type:
- Article
Melatonin as a Therapy for Preterm Brain Injury: What Is the Evidence?
- Published in:
- Antioxidants, 2023, v. 12, n. 8, p. 1630, doi. 10.3390/antiox12081630
- By:
- Publication type:
- Article
Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 9, p. 1186, doi. 10.3390/pharmaceutics16091186
- By:
- Publication type:
- Article
Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 10, p. 1295, doi. 10.1002/jcph.2462
- By:
- Publication type:
- Article